{"schema_version":"secwatch.filing_event.v1","accession":"0001549084-23-000004","form_type":"8-K/A","ticker":"CHRN","cik":"0001549084","company_name":"EKSO BIONICS HOLDINGS, INC.","filed_at":"2023-02-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.525591+00:00","generated_at":"2026-06-19T09:22:45.302720+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Ekso Bionics acquires Parker Hannifin's HMC business for $10M; HMC had $2.2M op loss in FY2022","bullets":["Acquisition closed Dec 5, 2022; purchase price $10M: $5M cash + $5M subordinated zero-coupon note due Sep 2027.","HMC FY2022 (Jun 2022) revenue $4.3M, operating loss $2.2M; FY2021 loss $4.0M on $2.7M revenue.","Pro forma 9mo Sep 2022 combined net loss $14.8M ($1.14 diluted EPS) vs Ekso standalone $11.9M loss.","Preliminary purchase price allocation: $5.2M intangible assets, $0.7M goodwill, $1.0M property step-ups.","HMC unaudited 3mo Sep 2022 revenue $390k, operating loss $1.1M."],"urls":{"canonical":"https://secwatch.observer/filing/0001549084-23-000004","json":"https://secwatch.observer/filing/0001549084-23-000004.json","markdown":"https://secwatch.observer/filing/0001549084-23-000004.md","text":"https://secwatch.observer/filing/0001549084-23-000004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1549084/000154908423000004/0001549084-23-000004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1549084/000154908423000004/ekso-20221205.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T09:22:45.302720+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}